Medical AI Alliance
← Company Index
Healthcare InfrastructureKOSPI 044820230 approvals

COSMAX BTI, INC.

Official website

Founded in 1992 and listed on KOSPI in 2006, COSMAX BTI is the COSMAX Group holding company overseeing health food and cosmetics affiliates.

As of 2026-10-10, COSMAX BTI, INC. has 20 Korean MFDS device approvals, 210 Korean MFDS drug approvals, 59 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Products & technology

  • Cosmetics (mask pack) manufacturingCosmetics manufacturing and wholesale
  • Global raw-material procurement and export agencyAffiliate support service

Regulatory approvals

data.go.kr

210 Korean MFDS drug approvals · 2007–2026 / 20 Korean MFDS device approvals · 2014–2023

  • MFDS drugSubsidiary: 코스맥스파마 주식회사Keypainibuprofen capsule2026-09-30
    Drug · OTC · Notification202602945
  • MFDS drugSubsidiary: 코스맥스파마 주식회사ComefreeSoft Cap.2026-07-03
    Drug · OTC · Notification202601940
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Dulco Liquid Gel Enteric Soft Capsule2026-05-20
    Drug · OTC · Notification202601473
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Epo Soft capsule2026-04-09
    Drug · OTC · Notification202601014
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Exentra Cold Soft capsule2026-03-03
    Drug · OTC · Notification202600634
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Exentra Nose Soft capsule2026-02-09
    Drug · OTC · Notification202600353
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Exentra Cold Soft capsule2025-12-24
    Drug · OTC · Notification202503378
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Exentra Cough Soft Capsule2025-12-24
    Drug · OTC · Notification202503379
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Exentra Nose Soft capsule2025-12-19
    Drug · OTC · Notification202503332
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Dutaset Tab. 0.5mg2025-12-18
    Drug · Prescription · Approval202503311
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Exentra Tab. 500mg2025-11-07
    Drug · OTC · Notification202502888
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Ginkgo Mini Tab. 80mg2025-09-29
    Drug · OTC · Notification202502572
Show 68 more
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Moaphen Q Soft capsule2025-06-02
    Drug · OTC · Notification202501361
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Caripoten Soft Capsule2025-02-17
    Drug · OTC · Notification202500352
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Hugh and Sol Plus Soft capsule2025-01-03
    Drug · OTC · Notification202500015
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Phamflucold Plus Soft capsule2024-08-22
    Drug · OTC · Notification202402023
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Phamflucough Plus Soft capsule2024-07-29
    Drug · OTC · Notification202401829
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Hugh and Sol Nose Soft capsule2024-06-25
    Drug · OTC · Notification202401530
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Magsent Tab.2024-05-28
    Drug · OTC · Notification202401300
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Ocu-A soft cap.2024-05-28
    Drug · OTC · Notification202401310
  • MFDS drugSubsidiary: 코스맥스파마 주식회사CocoMax Soft Cap.2023-11-28
    Drug · OTC · Notification202303232
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Monteresin tablet (Montelukast sodium, Levocetirizine HCL)2023-11-14
    Drug · Prescription · Approval202303129
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Easy Clean Enteric Soft Capsule2023-10-30
    Drug · OTC · Notification202303018
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Tuls sokpyeon Tab.2023-08-14
    Drug · OTC · Notification202302436
  • MFDSSubsidiary: 코스맥스파마 주식회사IVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2023-05-22
    Product approval · Class 3체외 제허 23-601 호
  • MFDS drugSubsidiary: 코스맥스파마 주식회사B-col Soft Cap.2023-03-30
    Drug · OTC · Notification202301087
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Dapasita Tabs. 10/100mg2023-02-21
    Drug · Prescription · Approval202300644
  • MFDS drugSubsidiary: 코스맥스파마 주식회사BQONES soft cap.2023-01-13
    Drug · OTC · Notification202300250
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Ginkgo Max Tab. 240mg2023-01-02
    Drug · OTC · Notification202300013
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Kickcold-S Soft Cap.2022-11-21
    Drug · OTC · Notification202204176
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Ichame Cough Soft capsule2022-11-14
    Drug · OTC · Notification202204088
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Kickcough-S Soft Cap.2022-11-14
    Drug · OTC · Notification202204092
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Ichame Cold soft capsule2022-11-11
    Drug · OTC · Notification202204075
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Ichame Nose Soft capsule2022-11-11
    Drug · OTC · Notification202204076
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Kicknose-S Soft Capsule2022-10-27
    Drug · OTC · Notification202203931
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Home Run Tab. 5mg (Tadalafil)2022-09-15
    Drug · Prescription · Approval202203569
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Home Run Tab. 20mg (Tadalafil)2022-09-15
    Drug · Prescription · Approval202203570
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Home Run Tab. 10mg (Tadalafil)2022-09-15
    Drug · Prescription · Approval202203571
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Magcuen Soft capsule2022-08-10
    Drug · OTC · Notification202203241
  • MFDSSubsidiary: 코스맥스파마 주식회사IVD reagents for tumor marker2022-08-03
    Product approval · Class 3체외 제허 22-519 호
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Total cough soft cap.2022-06-22
    Drug · OTC · Notification202202609
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Total plu soft cap.2022-06-14
    Drug · OTC · Notification202202488
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Machrong Soft capsule2022-05-30
    Drug · OTC · Notification202202289
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Total nose soft cap.Revoked2022-05-11
    Drug · OTC · Notification202201939
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Creen nose Soft capsule2022-04-25
    Drug · OTC · Notification202201683
  • MFDS drugSubsidiary: 코스맥스파마 주식회사V COL N Soft capsuleRevoked2022-04-19
    Drug · OTC · Notification202201614
  • MFDS drugSubsidiary: 코스맥스파마 주식회사V co N Soft capsuleRevoked2022-03-31
    Drug · OTC · Notification202201275
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Mag Q Soft capsuleRevoked2022-01-14
    Drug · OTC · Notification202200249
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Igapen Soft capsuleRevoked2022-01-14
    Drug · OTC · Notification202200250
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Magmeta Soft capsule2021-12-29
    Drug · OTC · Notification202108167
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Karomax SuspensionRevoked2021-12-13
    Drug · Prescription · Notification202107907
  • MFDSSubsidiary: 코스맥스파마 주식회사IVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2021-11-25
    Product approval · Class 3체외 제허 21-953 호
  • MFDSSubsidiary: 코스맥스파마 주식회사Specimen transport mediaRevoked2021-10-13
    Product approval · Class 1체외 제신 21-1359 호
  • MFDSSubsidiary: 코스맥스파마 주식회사IVD reagents for extracting nucleic acidsRevoked2021-10-06
    Product approval · Class 1체외 제신 21-1332 호
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Flu Nose Soft capsuleRevoked2021-08-19
    Drug · OTC · Notification202106040
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Ban4 Cold Soft capsuleRevoked2021-08-13
    Drug · OTC · Notification202105942
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Flu Cold Soft capsuleRevoked2021-08-13
    Drug · OTC · Notification202105959
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Flu Cough Soft capsuleRevoked2021-08-13
    Drug · OTC · Notification202105960
  • MFDSSubsidiary: 코스맥스파마 주식회사IVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-08-03
    Product approval · Class 3체외 제허 21-656 호
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Omni Cold Soft capsuleRevoked2021-08-03
    Drug · OTC · Notification202105715
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Omni Nose Soft capsuleRevoked2021-08-03
    Drug · OTC · Notification202105716
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Omni Cough Soft capsuleRevoked2021-08-03
    Drug · OTC · Notification202105717
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Ban4 Cough Soft capsuleRevoked2021-08-03
    Drug · OTC · Notification202105718
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Ban4 Nose Soft capsuleRevoked2021-08-03
    Drug · OTC · Notification202105719
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Omnifein SoftcapsuleRevoked2021-07-16
    Drug · OTC · Notification202105407
  • MFDS drugSubsidiary: 코스맥스파마 주식회사OmnifenSoftcapsuleRevoked2021-06-23
    Drug · OTC · Notification202104816
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Antisto Soft Capsule2021-04-20
    Drug · OTC · Notification202103216
  • MFDSSubsidiary: 코스맥스파마 주식회사IVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2021-04-05
    Product approval · Class 3체외 제허 21-251 호
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Vibrex Soft capsule2021-02-22
    Drug · OTC · Notification202101735
  • MFDS drugSubsidiary: 코스맥스파마 주식회사DoneMax Tab 5mgRevoked2021-01-25
    Drug · Prescription · Approval202100730
  • MFDS drugSubsidiary: 코스맥스파마 주식회사DoneMax Tab 10mgRevoked2021-01-25
    Drug · Prescription · Approval202100731
  • MFDS drugSubsidiary: 코스맥스파마 주식회사PharmpyounanD tab2020-12-23
    Drug · OTC · Notification202009163
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Teranose Soft CapsuleRevoked2020-12-15
    Drug · OTC · Notification202008795
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Teracough Soft CapsuleRevoked2020-12-10
    Drug · OTC · Notification202008676
  • MFDS drugSubsidiary: 코스맥스파마 주식회사TeraCold Soft Capsule2020-11-11
    Drug · OTC · Notification202007739
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Greenday Enteric Soft CapsuleRevoked2020-10-26
    Drug · OTC · Notification202007330
  • MFDS drugSubsidiary: 코스맥스파마 주식회사Bicomax Tab.Revoked2020-10-15
    Drug · OTC · Notification202007064
  • MFDSSubsidiary: 코스맥스파마 주식회사IVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-10-06
    Product approval · Class 3체외 제허 20-863 호
  • MFDSSubsidiary: 코스맥스파마 주식회사Real-time gene amplificator, nucleic acid2020-09-22
    Product approval · Class 2체외 제인 20-4872 호
  • MFDS drugSubsidiary: 코스맥스파마 주식회사mediNphen Inj2020-08-05
    Drug · Prescription · Notification202005669

Showing the 80 most recent of 230 records.

R&D and key agreements

Source: DART corporate disclosure

개별인정형 원료(코스맥스바이오) · 체지방 감소 등 · 6건 확보 · 6 individually approved ingredients incl. new lime-cacao complex extract approved Dec 2025

개별인정형 원료(코스맥스엔비티) · 피부건강 등 · 9건 확보 · 9 individually approved ingredients incl. new wheat germ extract (Ceramosides) approved March 2025

Key disclosures

KRX KIND via OpenDART
Show 7 more events

Publications

PubMed · affiliation-matched
Show 49 more publications

Patents

KIPRIS · applicant-matched
Show 129 more patents

AI reads

MAA server logs · IP-verified
132
Times AI engines pulled COSMAX BTI, INC.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

4
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

128
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

13
live 0
Last 7 days
97
live 2
Last 30 days
132
live 4
All time
  • OpenAIChatGPT-Userlive3
  • AnthropicClaude-Userlive1
  • OpenAIOAI-SearchBot100
  • GoogleGoogleOther19
  • PerplexityPerplexityBot6
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 8, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for COSMAX BTI, INC. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsHealthcare Infrastructure

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

SD BIOSENSOR INC.9 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

Boditech Med Inc.8 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

GC Medical Science Corporation8 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

NanoenTek,Inc.6 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

HUMASIS CO., LTD.6 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

OSANG HEALTHCARE CO.,LTD.6 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

PCL. Inc6 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

CALTH. Inc6 shared

Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.

RollingStone Co., Ltd.5 shared

KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.

Sugentech, Inc.5 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

Access Bio, Inc.5 shared

Founded in 2002 and KOSDAQ-listed in 2013, Access Bio develops rapid diagnostic tests for malaria, COVID-19, and other infectious diseases.

DONG-A ST CO.,LTD5 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition